{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:42:52Z","timestamp":1790376172274,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-1-001"],"award-info":[{"award-number":["2016-I2M-1-001"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2017-I2M-3-009"],"award-info":[{"award-number":["2017-I2M-3-009"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2017-12M-4-002"],"award-info":[{"award-number":["2017-12M-4-002"]}]},{"name":"National Key Research and Development Program of China","award":["2018YFC1003500"],"award-info":[{"award-number":["2018YFC1003500"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672472"],"award-info":[{"award-number":["81672472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672461"],"award-info":[{"award-number":["81672461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31725013"],"award-info":[{"award-number":["31725013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Basic Research Program of China","award":["2015CB943001"],"award-info":[{"award-number":["2015CB943001"]}]},{"name":"State Key Project on Infection Diseases of China","award":["2017ZX10201021-007-003"],"award-info":[{"award-number":["2017ZX10201021-007-003"]}]},{"name":"State Key Laboratory Special fund from the Ministry of Science","award":["2060204"],"award-info":[{"award-number":["2060204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) is one of the most common malignancies, and it\u2019s expected that the CRC burden will substantially increase in the next two decades. New biomarkers for targeted treatment and associated molecular mechanism of tumorigenesis remain to be explored. In this study, we investigated whether PDCD6 plays an oncogenic role in colorectal cancer and its underlying mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Programmed cell death protein 6 (PDCD6) expression in CRC samples were analyzed by immunohistochemistry and immunofluorescence. The prognosis between PDCD6 and clinical features were analyzed. The roles of PDCD6 in cellular proliferation and tumor growth were measured by using CCK8, colony formation, and tumor xenograft in nude mice. RNA-sequence (RNA-seq), Mass Spectrum (MS), Co-Immunoprecipitation (Co-IP) and Western blot were utilized to investigate the mechanism of tumor progression. Immunohistochemistry (IHC) and quantitative real-time PCR (qRT-PCR) were performed to determine the correlation of PDCD6 and MAPK pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Higher expression levels of PDCD6 in tumor tissues were associated with a poorer prognosis in patients with CRC. Furthermore, PDCD6 increased cell proliferation in vitro and tumor growth in vivo. Mechanistically, RNA-seq showed that PDCD6 could affect the activation of the MAPK signaling pathway. PDCD6 interacted with c-Raf, resulting in the activation of downstream c-Raf\/MEK\/ERK pathway and the upregulation of core cell proliferation genes such as MYC and JUN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings reveal the oncogenic effect of PDCD6 in CRC by activating c-Raf\/MEK\/ERK pathway and indicate that PDCD6 might be a potential prognostic indicator and therapeutic target for patients with colorectal cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-020-01632-9","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T09:02:04Z","timestamp":1598864524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf\/MEK\/ERK activation"],"prefix":"10.1186","volume":"39","author":[{"given":"Xiaojuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amannisa","family":"Tuersuntuoheti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shida","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuechao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandula","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"1632_CR1","first-page":"4","volume":"18","author":"Y Guo","year":"2017","unstructured":"Guo Y, Bao Y, Yang W. Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis. Int J Mol Sci. 2017;18:4.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1632_CR2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"issue":"3","key":"1632_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177\u201393.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1632_CR4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","volume":"89","author":"EK Kim","year":"2015","unstructured":"Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89(6):867\u201382.","journal-title":"Arch Toxicol"},{"issue":"21","key":"1632_CR5","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1158\/0008-5472.CAN-18-1045","volume":"78","author":"TF Eleveld","year":"2018","unstructured":"Eleveld TF, Schild L, Koster J, Zwijnenburg DA, Alles LK, Ebus ME, Volckmann R, Tijtgat GA, van Sluis P, Versteeg R, et al. RAS-MAPK pathway-driven tumor progression is associated with loss of CIC and other genomic aberrations in neuroblastoma. Cancer Res. 2018;78(21):6297\u2013307.","journal-title":"Cancer Res"},{"issue":"5","key":"1632_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm3979","volume":"16","author":"H Lavoie","year":"2015","unstructured":"Lavoie H, Therrien M. Regulation of RAF protein kinases in ERK signalling. Nat Rev Mol Cell Biol. 2015;16(5):281\u201398.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"1632_CR7","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1074\/jbc.M110498200","volume":"277","author":"AN Anselmo","year":"2002","unstructured":"Anselmo AN, Bumeister R, Thomas JM, White MA. Critical contribution of linker proteins to Raf kinase activation. J Biol Chem. 2002;277(8):5940\u20133.","journal-title":"J Biol Chem"},{"issue":"4","key":"1632_CR8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1042\/BST20140057","volume":"42","author":"AU Newlaczyl","year":"2014","unstructured":"Newlaczyl AU, Hood FE, Coulson JM, Prior IA. Decoding RAS isoform and codon-specific signalling. Biochem Soc Trans. 2014;42(4):742\u20136.","journal-title":"Biochem Soc Trans"},{"key":"1632_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2016.12.001","volume":"53","author":"E Martinelli","year":"2017","unstructured":"Martinelli E, Morgillo F, Troiani T, Ciardiello F. Cancer resistance to therapies against the EGFR-RAS-RAF pathway: the role of MEK. Cancer Treat Rev. 2017;53:61\u20139.","journal-title":"Cancer Treat Rev"},{"issue":"34","key":"1632_CR10","doi-asserted-by":"crossref","first-page":"20990","DOI":"10.1074\/jbc.272.34.20990","volume":"272","author":"GJ Clark","year":"1997","unstructured":"Clark GJ, Drugan JK, Rossmann KL, Carpenter JW, RogersGraham K, Fu H, Der CJ, Campbell SL. 14-3-3 zeta negatively regulates Raf-1 activity by interactions with the Raf-1 cysteine-rich domain. J Biol Chem. 1997;272(34):20990\u20133.","journal-title":"J Biol Chem"},{"issue":"11","key":"1632_CR11","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1128\/MCB.18.11.6698","volume":"18","author":"M Daub","year":"1998","unstructured":"Daub M, Jockel J, Quack T, Weber CK, Schmitz F, Rapp UR, Wittinghofer A, Block C. The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation. Mol Cell Biol. 1998;18(11):6698\u2013710.","journal-title":"Mol Cell Biol"},{"issue":"26","key":"1632_CR12","doi-asserted-by":"crossref","first-page":"24931","DOI":"10.1074\/jbc.M413929200","volume":"280","author":"N Trakul","year":"2005","unstructured":"Trakul N, Menard RE, Schade GR, Qian Z, Rosner MR. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem. 2005;280(26):24931\u201340.","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"1632_CR13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10555-012-9365-9","volume":"31","author":"J Escara-Wilke","year":"2012","unstructured":"Escara-Wilke J, Yeung K, Keller ET. Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev. 2012;31(3\u20134):615\u201320.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"1632_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jprot.2010.10.006","volume":"74","author":"JJ Bonfiglio","year":"2011","unstructured":"Bonfiglio JJ, Maccarrone G, Rewerts C, Holsboer F, Arzt E, Turck CW, Silberstein S. Characterization of the B-Raf interactome in mouse hippocampal neuronal cells. J Proteome. 2011;74(2):186\u201398.","journal-title":"J Proteome"},{"issue":"4","key":"1632_CR15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bbrc.2018.03.084","volume":"498","author":"H Guo","year":"2018","unstructured":"Guo H, Zhang XY, Peng J, Huang Y, Yang Y, Liu Y, Guo XX, Hao Q, An S, Xu TR. RUVBL1, a novel C-RAF-binding protein, activates the RAF\/MEK\/ERK pathway to promote lung cancer tumorigenesis. Biochem Biophys Res Commun. 2018;498(4):932\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1632_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijms17091401","volume":"17","author":"M Maki","year":"2016","unstructured":"Maki M, Takahara T, Shibata H. Multifaceted Roles of ALG-2 in Ca(2+)-Regulated Membrane Trafficking. Int J Mol Sci. 2016;17:9.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1632_CR17","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/oxfordjournals.jbchem.a022235","volume":"124","author":"M Maki","year":"1998","unstructured":"Maki M, Yamaguchi K, Kitaura Y, Satoh H, Hitomi K. Calcium-induced exposure of a hydrophobic surface of mouse ALG-2, which is a member of the penta-EF-hand protein family. J Biochem. 1998;124(6):1170\u20137.","journal-title":"J Biochem"},{"issue":"8","key":"1632_CR18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11427-011-4204-8","volume":"54","author":"M Maki","year":"2011","unstructured":"Maki M, Suzuki H, Shibata H. Structure and function of ALG-2, a penta-EF-hand calcium-dependent adaptor protein. Sci China Life Sci. 2011;54(8):770\u20139.","journal-title":"Sci China Life Sci"},{"issue":"2","key":"1632_CR19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1006\/bbrc.2001.5769","volume":"288","author":"YS Jung","year":"2001","unstructured":"Jung YS, Kim KS, Kim KD, Lim JS, Kim JW, Kim E. Apoptosis-linked gene 2 binds to the death domain of Fas and dissociates from Fas during Fas-mediated apoptosis in Jurkat cells. Biochem Biophys Res Commun. 2001;288(2):420\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1632_CR20","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1128\/MCB.22.12.4094-4100.2002","volume":"22","author":"IK Jang","year":"2002","unstructured":"Jang IK, Hu R, Lacana E, D'Adamio L, Gu H. Apoptosis-linked gene 2-deficient mice exhibit Normal T-cell development and function. Mol Cell Biol. 2002;22(12):4094\u2013100.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1632_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9440(10)63632-2","volume":"163","author":"JM la Cour","year":"2003","unstructured":"la Cour JM, Mollerup J, Winding P, Tarabykina S, Sehested M, Berchtold MW. Up-regulation of ALG-2 cancer tissue in hepatomas and lung. Am J Pathol. 2003;163(1):81\u20139.","journal-title":"Am J Pathol"},{"issue":"2","key":"1632_CR22","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.18632\/oncotarget.13740","volume":"8","author":"J Qin","year":"2017","unstructured":"Qin J, Li D, Zhou Y, Xie S, Du X, Hao Z, Liu R, Liu X, Liu M, Zhou J. Apoptosis-linked gene 2 promotes breast cancer growth and metastasis by regulating the cytoskeleton. Oncotarget. 2017;8(2):2745\u201357.","journal-title":"Oncotarget"},{"key":"1632_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1479-5876-10-31","volume":"10","author":"D Su","year":"2012","unstructured":"Su D, Xu H, Feng J, Gao Y, Gu L, Ying L, Katsaros D, Yu H, Xu S, Qi M. PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer. J Transl Med. 2012;10:31.","journal-title":"J Transl Med"},{"issue":"2","key":"1632_CR24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s13277-011-0280-4","volume":"33","author":"JH Yoon","year":"2012","unstructured":"Yoon JH, Choi YJ, Kim SG, Nam SW, Lee JY, Park WS. Programmed cell death 6 (PDCD6) as a prognostic marker for gastric cancers. Tumour Biol. 2012;33(2):485\u201394.","journal-title":"Tumour Biol"},{"issue":"1","key":"1632_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2008.11.021","volume":"378","author":"BR Hoj","year":"2009","unstructured":"Hoj BR, la Cour JM, Mollerup J, Berchtold MW. ALG-2 knockdown in HeLa cells results in G2\/M cell cycle phase accumulation and cell death. Biochem Biophys Res Commun. 2009;378(1):145\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1632_CR26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbrc.2017.03.032","volume":"486","author":"D Zhang","year":"2017","unstructured":"Zhang D, Wang F, Pang Y, Zhao E, Zhu S, Chen F, Cui H. ALG2 regulates glioblastoma cell proliferation, migration and tumorigenicity. Biochem Biophys Res Commun. 2017;486(2):300\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1632_CR27","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00018-010-0559-4","volume":"68","author":"H Wang","year":"2011","unstructured":"Wang H, Song W, Hu T, Zhang N, Miao S, Zong S, Wang L. Fank1 interacts with Jab1 and regulates cell apoptosis via the AP-1 pathway. Cell Mol Life Sci. 2011;68(12):2129\u201339.","journal-title":"Cell Mol Life Sci"},{"issue":"16","key":"1632_CR28","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1128\/JVI.79.16.10308-10329.2005","volume":"79","author":"N Sharma-Walia","year":"2005","unstructured":"Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, Chandran B. ERK1\/2 and MEK1\/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol. 2005;79(16):10308\u201329.","journal-title":"J Virol"},{"issue":"2","key":"1632_CR29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.taap.2008.01.009","volume":"229","author":"M Le Mercier","year":"2008","unstructured":"Le Mercier M, Lefranc F, Mijatovic T, Debeir O, Haibe-Kains B, Bontempi G, Decaestecker C, Kiss R, Mathieu V. Evidence of galectin-1 involvement in glioma chemoresistance. Toxicol Appl Pharmacol. 2008;229(2):172\u201383.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1632_CR30","doi-asserted-by":"crossref","first-page":"109361","DOI":"10.1016\/j.biopha.2019.109361","volume":"118","author":"L Yu","year":"2019","unstructured":"Yu L, Wang C, Pan F, Liu Y, Ren X, Zeng H, Shi Y. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt\/beta-catenin signaling. Biomed Pharmacother. 2019;118:109361.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1632_CR31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3892\/ijo.2016.3355","volume":"48","author":"L Li","year":"2016","unstructured":"Li L, Yu J, Duan Z, Dang HX. The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma. Int J Oncol. 2016;48(4):1457\u201366.","journal-title":"Int J Oncol"},{"issue":"7","key":"1632_CR32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ncb2271","volume":"13","author":"F Calvo","year":"2011","unstructured":"Calvo F, Sanz-Moreno V, Agudo-Ibanez L, Wallberg F, Sahai E, Marshall CJ, Crespo P. RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. Nat Cell Biol. 2011;13(7):819\u201326.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"1632_CR33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","volume":"157","author":"S Groschel","year":"2014","unstructured":"Groschel S, Sanders MA, Hoogenboezem R, de Wit E, Bouwman BAM, Erpelinck C, van der Velden VHJ, Havermans M, Avellino R, van Lom K, et al. A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell. 2014;157(2):369\u201381.","journal-title":"Cell"},{"issue":"7","key":"1632_CR34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0968-0004(94)90005-1","volume":"19","author":"J Avruch","year":"1994","unstructured":"Avruch J, Zhang XF, Kyriakis JM. Raf meets Ras - completing the framework of a signal-transduction pathway. Trends Biochem Sci. 1994;19(7):279\u201383.","journal-title":"Trends Biochem Sci"},{"issue":"12","key":"1632_CR35","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1021\/acs.jmedchem.6b01862","volume":"60","author":"GA Nishiguchi","year":"2017","unstructured":"Nishiguchi GA, Rico A, Tanner H, Aversa RJ, Taft BR, Subramanian S, Setti L, Burger MT, Wan L, Tamez V, et al. Design and discovery of N-(2-Methyl-5\u2032-morpholino-6\u2032-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3\u2032-bipyridin]-5-y l)-3-(trifluoromethyl) benzamide (RAF709): A potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancers. J Med Chem. 2017;60(12):4869\u201381.","journal-title":"J Med Chem"},{"issue":"5","key":"1632_CR36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00011-011-0431-5","volume":"61","author":"T Yamaguchi","year":"2012","unstructured":"Yamaguchi T, Kakefuda R, Tanimoto A, Watanabe Y, Tajima N. Suppressive effect of an orally active MEK1\/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide. Inflamm Res. 2012;61(5):445\u201354.","journal-title":"Inflamm Res"},{"issue":"4","key":"1632_CR37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/1535-7163.MCT-11-0989","volume":"11","author":"JG Greger","year":"2012","unstructured":"Greger JG, Eastman SD, Zhang V, Bleam MR, Hughes AM, Smitheman KN, Dickerson SH, Laquerre SG, Liu L, Gilmer TM. Combinations of BRAF, MEK, and PI3K\/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations. Mol Cancer Ther. 2012;11(4):909\u201320.","journal-title":"Mol Cancer Ther"},{"issue":"16","key":"1632_CR38","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-11-3227","volume":"18","author":"JS Khalili","year":"2012","unstructured":"Khalili JS, Yu X, Wang J, Hayes BC, Davies MA, Lizee G, Esmaeli B, Woodman SE. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012;18(16):4345\u201355.","journal-title":"Clin Cancer Res"},{"issue":"22","key":"1632_CR39","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/cncr.28864","volume":"120","author":"M Burotto","year":"2014","unstructured":"Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014;120(22):3446\u201356.","journal-title":"Cancer"},{"issue":"3","key":"1632_CR40","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cellsig.2011.11.006","volume":"24","author":"SH Park","year":"2012","unstructured":"Park SH, Lee JH, Lee GB, Byun HJ, Kim BR, Park CY, Kim HB, Rho SB. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-kappaB pathways. Cell Signal. 2012;24(3):726\u201333.","journal-title":"Cell Signal"},{"issue":"22","key":"1632_CR41","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291\u2013310.","journal-title":"Oncogene"},{"issue":"5","key":"1632_CR42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccell.2017.04.002","volume":"31","author":"X Chen","year":"2017","unstructured":"Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H, Coupland SE, Roose JP, Bastian BC. RasGRP3 mediates MAPK pathway activation in GNAQ mutant Uveal melanoma. Cancer Cell. 2017;31(5):685\u201396 e686.","journal-title":"Cancer Cell"},{"issue":"6","key":"1632_CR43","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/cncr.22520","volume":"109","author":"M Cekanova","year":"2007","unstructured":"Cekanova M, Majidy M, Masi T, Al-Wadei HA, Schuller HM. Overexpressed Raf-1 and phosphorylated cyclic adenosine 3\u2032-5\u2032-monophosphatate response element-binding protein are early markers for lung adenocarcinoma. Cancer. 2007;109(6):1164\u201373.","journal-title":"Cancer"},{"issue":"1","key":"1632_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/erm.09.78","volume":"10","author":"MR Lackner","year":"2010","unstructured":"Lackner MR. Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways. Expert Rev Mol Diagn. 2010;10(1):75\u201387.","journal-title":"Expert Rev Mol Diagn"},{"issue":"19","key":"1632_CR45","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1242\/jcs.00078","volume":"115","author":"MC Nowycky","year":"2002","unstructured":"Nowycky MC. Intracellular calcium signaling. J Cell Sci. 2002;115(19):3715\u20136.","journal-title":"J Cell Sci"},{"issue":"5","key":"1632_CR46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2374","volume":"8","author":"HL Roderick","year":"2008","unstructured":"Roderick HL, Cook SJ. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer. 2008;8(5):361\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"1632_CR47","doi-asserted-by":"crossref","first-page":"14053","DOI":"10.1074\/jbc.M008649200","volume":"276","author":"Y Kitaura","year":"2001","unstructured":"Kitaura Y, Matsumoto S, Satoh H, Hitomi K, Maki M. Peflin and ALG-2, members of the penta-EF-hand protein family, form a heterodimer that dissociates in a Ca2+\u2212dependent manner. J Biol Chem. 2001;276(17):14053\u20138.","journal-title":"J Biol Chem"},{"issue":"11","key":"1632_CR48","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1091\/mbc.e06-05-0444","volume":"17","author":"A Yamasaki","year":"2006","unstructured":"Yamasaki A, Tani K, Yamamoto A, Kitamura N, Komada M. The Ca2+\u2212binding protein ALG-2 is recruited to endoplasmic reticulum exit sites by Sec31A and stabilizes the localization of Sec31A. Mol Biol Cell. 2006;17(11):4876\u201387.","journal-title":"Mol Biol Cell"},{"issue":"46","key":"1632_CR49","doi-asserted-by":"crossref","first-page":"33361","DOI":"10.1074\/jbc.M113.497479","volume":"288","author":"K Sasaki-Osugi","year":"2013","unstructured":"Sasaki-Osugi K, Imoto C, Takahara T, Shibata H, Maki M. Nuclear ALG-2 protein interacts with Ca2+ homeostasis endoplasmic reticulum protein (CHERP) Ca2+\u2212dependently and participates in regulation of alternative splicing of inositol trisphosphate receptor type 1 (IP3R1) pre-mRNA. J Biol Chem. 2013;288(46):33361\u201375.","journal-title":"J Biol Chem"},{"issue":"2","key":"1632_CR50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.cdd.4400456","volume":"6","author":"M Missotten","year":"1999","unstructured":"Missotten M, Nichols A, Rieger K, Sadoul R. Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ. 1999;6(2):124\u20139.","journal-title":"Cell Death Differ"},{"issue":"5","key":"1632_CR51","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1006\/bbrc.2002.6600","volume":"291","author":"H Satoh","year":"2002","unstructured":"Satoh H, Shibata H, Nakano Y, Kitaura Y, Maki M. ALG-2 interacts with the amino-terminal domain of annexin XI in a Ca(2+)-dependent manner. Biochem Biophys Res Commun. 2002;291(5):1166\u201372.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"1632_CR52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1570-9639(02)00445-4","volume":"1600","author":"H Satoh","year":"2002","unstructured":"Satoh H, Nakano Y, Shibata H, Maki M. The penta-EF-hand domain of ALG-2 interacts with amino-terminal domains of both annexin VII and annexin XI in a Ca2+\u2212dependent manner. Bba-Proteins Proteom. 2002;1600(1\u20132):61\u20137.","journal-title":"Bba-Proteins Proteom"},{"issue":"3","key":"1632_CR53","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1074\/jbc.274.3.1533","volume":"274","author":"P Vito","year":"1999","unstructured":"Vito P, Pellegrini L, Guiet C, D'Adamio L. Cloning of AIP1, a novel protein that associates with the apoptosis-linked gene ALG-2 in a Ca2+\u2212dependent reaction. J Biol Chem. 1999;274(3):1533\u201340.","journal-title":"J Biol Chem"},{"issue":"6","key":"1632_CR54","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1158\/0008-5472.CAN-17-2033","volume":"78","author":"W Shao","year":"2018","unstructured":"Shao W, Mishina YM, Feng Y, Caponigro G, Cooke VG, Rivera S, Wang Y, Shen F, Korn JM, Mathews Griner LA, et al. Antitumor properties of RAF709, a highly selective and potent inhibitor of RAF kinase dimers, in tumors driven by mutant RAS or BRAF. Cancer Res. 2018;78(6):1537\u201348.","journal-title":"Cancer Res"},{"issue":"19","key":"1632_CR55","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","volume":"377","author":"GV Long","year":"2017","unstructured":"Long GV, Hauschild A, Santinami M, Atkinson V, Mandala M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, et al. Adjuvant Dabrafenib plus Trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017;377(19):1813\u201323.","journal-title":"N Engl J Med"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-020-01632-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T19:21:06Z","timestamp":1627932066000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01632-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1632"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01632-9","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human tissues used in this study were approved by the ethics committee of the Cancer Hospital, Chinese Academy of Medical Sciences. Informed consent was obtained from each patient. Animal experiments were performed with the approval of the Peking Union Medical College Animal Care and Use Committees.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}